Tympanogen

Richmond, VA · Founded 2014 · Privately Held (backing)

Developer of medical devices for ear, nose, and throat (ENT) designed to replace traditional surgical procedures with clinic visits. Tympanogen is based in Richmond, VA and was founded in 2014. It was valued at $20.6 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $1.2 million seed round in Feb 2025.

PMV mark · valuation
$20.6M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$6.0M
Last round
Seed Round
Feb 2025
What is Tympanogen worth?
$20.6MPrivateMarketView mark · Oct 2026

Valued at $20.6M at its later-stage round, Dec 2025. Nothing has traded since.

Free account
More of Tympanogen with a free account
  • ·The complete investor list: 27 names
  • ·Watch Tympanogen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Tympanogen funding history

2 rounds
DateRoundRaisedPost-money
Feb 2025Seed Round$1.2M▮
Oct 2021Seed Round$1.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Tympanogen valuation

Tympanogen was valued at $20.6 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Tympanogen raised?

Tympanogen has raised $6 million in total; 2 of its rounds are on record. The largest on record was a $1.2 million seed round in Feb 2025.

Tympanogen has filed 3 Form Ds with the SEC since 2022, most recently in Mar 2025 ($1.2 million sold to 33 investors).

How Tympanogen's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Tympanogen, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Tympanogen

What is Tympanogen worth?
Tympanogen is valued at $20.6M as of Oct 2026. Valued at $20.6M at its later-stage round, Dec 2025. Nothing has traded since.
How much has Tympanogen raised?
Tympanogen has raised $6.0M in total funding across 2 recorded rounds.
When did Tympanogen last raise?
Tympanogen last raised in Feb 2025 (Seed Round), raising $1.2M.